James Chopas - Jan 16, 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: VP/Chief Accounting Officer
Signature: /s/ David Watson, attorney-in-fact for James Chopas
Stock symbol: APLS
Transactions as of: Jan 16, 2024
Transactions value $: $743,579
Form type: 4
Date filed: 1/17/2024, 04:45 PM
Previous filing: Oct 24, 2023
Next filing: Jan 23, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Award	$0	+8.31K	+25.43%	$0.00	41K	Jan 16, 2024	Direct	F1
transaction	APLS	Common Stock	Sale	-$57.7K	-864	-2.11%	$66.81	40.1K	Jan 16, 2024	Direct	F2

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Award	$801K	+12.1K		$66.30	12.1K	Jan 16, 2024	Common Stock	12.1K	$66.30	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This represents an award of Restricted Stock Units granted 01/16/2024 that vests annually from grant date over a four year period subject to continued service.
F2	This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/12/2024.
F3	This represents a stock option award granted 01/16/2024 that vests over a four year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.